[1] Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol, 2018; 218, S745−61.
[2] Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol, 2016; 48, 333−9.
[3] Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol, 2016; 594, 807−23.
[4] Murray E, Fernandes M, Fazel M, et al. Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review. BJOG, 2015; 122, 1062−72.
[5] Townsend R, Khalil A. Fetal growth restriction in twins. Best Pract Res Clin Obstet Gynaecol, 2018; 49, 79−88.
[6] Huang NN, Chen W, Jiang H, et al. Metabolic dynamics and prediction of sFGR and adverse fetal outcomes: a prospective longitudinal cohort study. BMC Med, 2023; 21, 455.
[7] Hollanders JJ, van der Voorn B, Kieviet N, et al. Interpretation of glucocorticoids in neonatal hair: a reflection of intrauterine glucocorticoid regulation? Endocr Connect, 2017; 6, 692-9.
[8] Gareri J, Koren G. Prenatal hair development: implications for drug exposure determination. Forensic Sci Int, 2010; 196, 27−31.
[9] Delplancke TDJ, de Seymour JV, Tong C, et al. Analysis of sequential hair segments reflects changes in the metabolome across the trimesters of pregnancy. Sci Rep, 2018; 8, 36.
[10] Sulek K, Han TL, Villas-Boas SG, et al. Hair metabolomics: identification of fetal compromise provides proof of concept for biomarker discovery. Theranostics, 2014; 4, 953−9.
[11] Yang J, Wei Y, Qi HB, et al. Neonatal hair profiling reveals a metabolic phenotype of monochorionic twins with selective intrauterine growth restriction and abnormal umbilical artery flow. Mol Med, 2020; 26, 37.
[12] Tse KY, Yu NYF, Leung KY, et al. Dichorionic twin pregnancy with selective fetal growth restriction: prognosis, complications and implications of Doppler abnormalities. Ultrasound Obstet Gynecol, 2025; 66, 186−93.
[13] D'Antonio F, Prasad S, Masciullo L, et al. Selective fetal growth restriction in dichorionic diamniotic twin pregnancy: systematic review and meta-analysis of pregnancy and perinatal outcomes. Ultrasound Obstet Gynecol, 2024; 63, 164−72.
[14] Khalil A, Beune I, Hecher K, et al. Consensus definition and essential reporting parameters of selective fetal growth restriction in twin pregnancy: a Delphi procedure. Ultrasound Obstet Gynecol, 2019; 53, 47−54.
[15] Favretto D, Cooper G, Andraus M, et al. The society of hair testing consensus on general recommendations for hair testing and drugs of abuse testing in hair. Drug Test Anal, 2023; 15, 1042−6.
[16] Smart KF, Aggio RBM, Van Houtte JR, et al. Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography-mass spectrometry. Nat Protoc, 2010; 5, 1709−29.
[17] de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ, 2007; 85, 660−7.
[18] Hosseini M, Carpenter RG, Mohammad K. Weight-for-height of children in Iran. Ann Hum Biol, 1999; 26, 537−47.
[19] Aggio RBM, Ruggiero K, Villas-Bôas SG. Pathway activity profiling (PAPi): from the metabolite profile to the metabolic pathway activity. Bioinformatics, 2010; 26, 2969−76.
[20] Gao J, Tarcea VG, Karnovsky A, et al. Metscape: a cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics, 2010; 26, 971−3.
[21] Yang J, Hou LL, Wang JF, et al. Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins. Gut, 2022; 71, 2451−62.
[22] Karatzoglou A, Meyer D, Hornik K. Support vector machines in R. J Stat Softw, 2006; 15, 1−28.
[23] Kumar A. Pre-processing and modelling using caret package in R. Int J Comput Appl, 2018; 81, 39−42.
[24] Beck MW. NeuralNetTools: visualization and analysis tools for neural networks. J Stat Softw, 2018; 85, 1−20.
[25] Hechenbichler K, Schliep K. Weighted k-nearest-neighbor techniques and ordinal classification. Discussion Paper 399, Ludwig-Maximilians-Universität München, 2004.
[26] Gajowniczek K, Ząbkowski T. ImbTreeEntropy: an R package for building entropy-based classification trees on imbalanced datasets. SoftwareX, 2021; 16, 100841.
[27] Pellegrino E, Jacques C, Beaufils N, et al. Machine learning random forest for predicting oncosomatic variant NGS analysis. Sci Rep, 2021; 11, 21820.
[28] Antonakopoulos N, Pateisky P, Liu B, et al. Selective fetal growth restriction in dichorionic twin pregnancies: diagnosis, natural history, and perinatal outcome. J Clin Med, 2020; 9, 1404.
[29] Kim HM, Cha HH, Seong WJ, et al. Prediction of maternal complications and neonatal outcome in dichorionic diamniotic twins with fetal weight discordancy measured by ultrasonography. Sci Rep, 2022; 12, 14889.
[30] Kolb B, Harker A, Gibb R. Principles of plasticity in the developing brain. Dev Med Child Neurol, 2017; 59, 1218−23.
[31] Stolt E, Olsen T, Elshorbagy A, et al. Sulfur amino acid restriction, energy metabolism and obesity: a study protocol of an 8-week randomized controlled dietary intervention with whole foods and amino acid supplements. J Transl Med, 2021; 19, 153.
[32] Paul BD, Sbodio JI, Snyder SH. Cysteine metabolism in neuronal redox homeostasis. Trends Pharmacol Sci, 2018; 39, 513−24.
[33] Vacek TP, Vacek JC, Tyagi N, et al. Autophagy and heart failure: a possible role for homocysteine. Cell Biochem Biophys, 2012; 62, 1−11.
[34] Cosmi E, Visentin S, Favretto D, et al. Selective intrauterine growth restriction in monochorionic twin pregnancies: markers of endothelial damage and metabolomic profile. Twin Res Hum Genet, 2013; 16, 816−26.
[35] Zhang GL, He ZM, Shi XM, et al. Discordant HIF1A mRNA levels and oxidative stress in placental shares of monochorionic twins with selective intra-uterine growth restriction. Placenta, 2015; 36, 297−303.
[36] Wu J, He Zm, Gao Y, et al. Placental NFE2L2 is discordantly activated in monochorionic twins with selective intrauterine growth restriction and possibly regulated by hypoxia. Free Radic Res, 2017; 51, 351−9.
[37] Lane SL, Dodson RB, Doyle AS, et al. Pharmacological activation of peroxisome proliferator-activated receptor γ (PPAR-γ) protects against hypoxia-associated fetal growth restriction. FASEB J, 2019; 33, 8999−9007.
[38] Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science, 2013; 339, 548−54.
[39] Nagpure BV, Bian JS. Brain, learning, and memory: role of H2S in neurodegenerative diseases. In: Moore PK, Whiteman M. Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide. Springer. 2015, 193-215.
[40] Xin DQ, Chu XL, Bai XM, et al. l-cysteine suppresses hypoxia-ischemia injury in neonatal mice by reducing glial activation, promoting autophagic flux and mediating synaptic modification via H2S formation. Brain Behav Immun, 2018; 73, 222−34.
[41] Blok EL, Burger RJ, Bergeijk JEV, et al. Oxidative stress biomarkers for fetal growth restriction in umbilical cord blood: a scoping review. Placenta, 2024; 154, 88−109.
[42] Terpstra M, Rao R, Tkac I. Region-specific changes in ascorbate concentration during rat brain development quantified by in vivo 1H NMR spectroscopy. NMR Biomed, 2010; 23, 1038−43.
[43] Barth A, Bauer R, Gedrange T, et al. Influence of hypoxia and hypoxia/hypercapnia upon brain and blood peroxidative and glutathione status in normal weight and growth-restricted newborn piglets. Exp Toxicol Pathol, 1998; 50, 402−10.
[44] Barth A, Bauer R, Klinger W, et al. Peroxidative status and glutathione content of the brain in normal weight and intra-uterine growth-retarded newborn piglets. Exp Toxicol Pathol, 1994; 45, 519−24.
[45] Hajjar I, Hayek SS, Goldstein FC, et al. Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study. J Neuroinflammation, 2018; 15, 17.
[46] Reid MV, Murray KA, Marsh ED, et al. Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol, 2012; 71, 640−53.
[47] Maliszewski-Hall AM, Alexander M, Tkáč I, et al. Differential effects of intrauterine growth restriction on the regional neurochemical profile of the developing rat brain. Neurochem Res, 2017; 42, 133−40.
[48] Bessières B, Cruz E, Alberini CM. Metabolomic profiling reveals a differential role for hippocampal glutathione reductase in infantile memory formation. eLife, 2021; 10, e68590.
[49] Rubio Gomez MA, Ibba M. Aminoacyl-tRNA synthetases. RNA, 2020; 26, 910−36.
[50] Fine AS, Nemeth CL, Kaufman ML, et al. Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination. J Neurodev Disord, 2019; 11, 29.
[51] Fuchs SA, Schene IF, Kok G, et al. Aminoacyl-tRNA synthetase deficiencies in search of common themes. Genet Med, 2019; 21, 319−30.
[52] Griffin SM, Pickard MR, Orme RP, et al. Nicotinamide alone accelerates the conversion of mouse embryonic stem cells into mature neuronal populations. PLoS One, 2017; 12, e0183358.
[53] Griffin SM, Pickard MR, Hawkins CP, et al. Nicotinamide restricts neural precursor proliferation to enhance catecholaminergic neuronal subtype differentiation from mouse embryonic stem cells. PLoS One, 2020; 15, e0233477.
[54] Brakedal B, Dölle C, Riemer F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab, 2022; 34, 396-407. e6.
[55] Jung KI, Han JS, Park CK. Neuroprotective effects of nicotinamide (vitamin B3) on neurodegeneration in diabetic rat retinas. Nutrients, 2022; 14, 1162.
[56] Ear PH, Chadda A, Gumusoglu SB, et al. Maternal nicotinamide riboside enhances postpartum weight loss, juvenile offspring development, and neurogenesis of adult offspring. Cell Rep, 2019; 26, 969-83. e4.